Sunday, October 13, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million

by Rishma Parpia
Zantac pills
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines, has agreed to pay between $200 to $250 million ...

Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study

by Rishma Parpia
Pfizer's BNT162b2 biologic
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as "Comirnaty") messenger RNA ...

Pharmaceutical Industry Reaping Billions of Dollars in Profits from Coronavirus Tests

by Rishma Parpia
coronavirus test
Since the beginning of the COVID-19 pandemic, public health officials have urged widespread testing for the presence of the SARS-CoV-2 ...

Sales of Pfizer COVID-19 Biologic for 2021-2022 May Near $70 Billion

by TVR Staff
rising profits
Based on better than expected sales of its experimental messenger RNA (mRNA) BNT162b2 COVID-19 biologic, New York-based pharmaceutical company Pfizer, ...

Former Pfizer Employee Whistleblower Alleges Falsified Data in COVID Biologic Trial

by Natasha Hobley
Pfizer whistleblower reveals falsified data
A former testing site researcher in Texas has alleged that Pfizer’s pre-licensure BNT162b2 (also known as "Comirnaty") COVID-19 biologic trials ...

Merck and Pfizer Seek Approval for COVID-19 Antiviral Drugs

by Rishma Parpia
Merck's antiviral drug Molnupiravir
Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize ...

Pfizer Raises Sales Forecast for COVID-19 Biologic to $33.5 Billion in 2021

by Rishma Parpia
revenue growth
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of ...

Existing Drugs Hold Promise for Treatment of COVID-19

by Kate Raines
other medications for COVID
Story Highlights A group of Israeli researchers have studied close to 3,000 approved drugs to see if any could be ...

Johnson & Johnson Recalls Carcinogen Containing Sunscreen Products

by Rishma Parpia
sunscreen
On July 14, 2021, Johnson and Johnson Consumer, Inc. voluntarily recalled all batches of five NEUTROGENA and AVEENO aerosol sunscreen ...

In this section

Search in Archive